RT Journal Article
T1 Quality of life in patients with fibromyalgia: contributions of disease symptoms, lifestyle and multi-medication
A1 Fernández-Feijoo, Fátima
A1 Samartín Veiga, Noelia
A1 Carrillo de la Peña, María Teresa
K1 Chronic pain
K1 Quality of life
K1 Lifestyle
K1 Anxiety
K1 Depression
K1 Multi-medication
AB Fibromyalgia (FM) is a disease characterized by the presence of chronic andwidespread musculoskeletal pain, which causes a high negative impact onthe quality of life (QoL). Although there are many studies about the QoLof patients with FM, it is unknown which variables have a main influenceon it. Therefore, in the present study, we aimed to determine which FMsymptoms predict a worse QoL and also to establish whether lifestyle andmulti-medication are associated to QoL.We assessed a sample of 134 womenwith FM using a semi-structured clinical interview to explore lifestyle (diet,exercise, smoking) and medication use, and questionnaires to cover the mainsymptoms of this disease and QoL (SF-36).We found that the patients with FMhad a poor QoL, being “physical pain” and “vitality” the most affected domains.A linear regression analysis showed that depression and anxiety assessedby HADS were the FM symptoms which most significantly predicted QoL,explaining 49% of the variance. Concerning lifestyle/medication influences,we found that multiple drug treatment and smoking also predicted a worseQoL (14%). Moreover, patients who practiced exercise regularly showed betterQoL than patients who did not (regardless of the severity of FM). Thus,our results suggest that treatment strategies to improve QoL in FM shouldbe focused on improving psychological distress, promoting regular exerciseand reducing smoking and multi-medication. The data highlights the role ofpositive self-management practices to improve QoL in FM
PB Frontiers Media
YR 2022
FD 2022
LK http://hdl.handle.net/10347/29896
UL http://hdl.handle.net/10347/29896
LA eng
NO Fernandez-Feijoo F, Samartin-Veiga N and Carrillo-de-la-Peña MT (2022) Quality of life in patients with fibromyalgia: contributions of disease symptoms, lifestyle and multi-medication. Front. Psychol. 13:924405
NO This study has been funded by the Spanish Government (Ministerio de Economía y Competitividad; ref PSI2016-75313- R) and Galician Government (IDT Plan. Grant 2021-PG011). In addition, NS-V was supported by a grant from the Spanish  Government (Ministerio de Economía y Competitividad; grant number: BES-2017-082684)
DS Minerva
RD 25 abr 2026